These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 12613533)

  • 1. Therapy-related myelodysplastic syndrome with monosomy 5 and 7 following successful therapy for acute promyelocytic leukemia with anthracyclines.
    Athanasiadou A; Saloum R; Zorbas I; Tsompanakou A; Batsis I; Fassas A; Anagnostopoulos A
    Leuk Lymphoma; 2002 Dec; 43(12):2409-11. PubMed ID: 12613533
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Therapy-related myelodysplastic syndrome with monosomy 5 after successful treatment of acute myeloid leukemia (M2).
    Ogasawara T; Yasuyama M; Kawauchi K
    Am J Hematol; 2005 Jun; 79(2):136-41. PubMed ID: 15929101
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Therapy-related acute myeloid leukaemia after successful therapy for acute promyelocytic leukaemia with t(15;17): a report of two cases and a review of the literature.
    Zompi S; Legrand O; Bouscary D; Blanc CM; Picard F; Casadevall N; Dreyfus F; Marie JP; Viguié F
    Br J Haematol; 2000 Sep; 110(3):610-3. PubMed ID: 10997972
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Therapy-related acute myeloid leukemia and myelodysplasia after successful treatment of acute promyelocytic leukemia.
    Zompi S; Viguié F
    Leuk Lymphoma; 2002 Feb; 43(2):275-80. PubMed ID: 11999558
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acquired acute myelogenous leukemia after therapy for acute promyelocytic leukemia with t(15;17): a case report and review of the literature.
    Betancourt-García RD; Castro J; Fernández AC; López-Enríquez A; Fradera J; Pacheco E
    P R Health Sci J; 2009 Jun; 28(2):146-50. PubMed ID: 19530558
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Therapy-related myelodysplastic syndrome-acute myelogenous leukemia in patients treated for acute promyelocytic leukemia: an emerging problem.
    Latagliata R; Petti MC; Fenu S; Mancini M; Spiriti MA; Breccia M; Brunetti GA; Avvisati G; Lo Coco F; Mandelli F
    Blood; 2002 Feb; 99(3):822-4. PubMed ID: 11806982
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Therapy-related myelodysplastic syndrome after eradication of acute promyelocytic leukemia: cytogenetic and molecular features.
    Au WY; Lam CC; Ma ES; Man C; Wan T; Kwong YL
    Hum Pathol; 2001 Jan; 32(1):126-9. PubMed ID: 11172306
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Secondary clonal cytogenetic abnormalities following successful treatment of acute promyelocytic leukemia.
    Batzios C; Hayes LA; He SZ; Quach H; McQuilten ZK; Wall M; Campbell LJ
    Am J Hematol; 2009 Nov; 84(11):715-9. PubMed ID: 19806661
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Secondary chronic myelomonocytic leukemia with monosomy 7 after successful treatment of acute promyelocytic leukemia.
    Jeddi R; Gouider E; Benneji H; Mnif S; Ben Abid H; Belhadjali Z; Meddeb B
    Pathol Biol (Paris); 2008 May; 56(3):162-3. PubMed ID: 18178033
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Monosomy 7 associated with pediatric acute myeloid leukemia (AML) and myelodysplastic syndrome (MDS): successful management by allogeneic hematopoietic stem cell transplant (HSCT).
    Trobaugh-Lotrario AD; Kletzel M; Quinones RR; McGavran L; Proytcheva MA; Hunger SP; Malcolm J; Schissel D; Hild E; Giller RH
    Bone Marrow Transplant; 2005 Jan; 35(2):143-9. PubMed ID: 15558042
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Therapy-related myeloid neoplasms after successful treatment for acute promyelocytic leukemia: a report of four cases and literature review].
    Wang Z; Xu MZ; Chen YF; Xue F; Zhang L; Hu YM; Li CW; Li SZ; Wang JX; Mi YC
    Zhonghua Xue Ye Xue Za Zhi; 2019 Dec; 40(12):1008-1014. PubMed ID: 32023731
    [No Abstract]   [Full Text] [Related]  

  • 12. Myelodysplastic syndrome after acute promyelocytic leukemia: the European APL group experience.
    Lobe I; Rigal-Huguet F; Vekhoff A; Desablens B; Bordessoule D; Mounier C; Ferrant A; Sanz M; Fey M; Chomienne C; Chevret S; Degos L; Fenaux P;
    Leukemia; 2003 Aug; 17(8):1600-4. PubMed ID: 12886249
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Isochromosome 1q in a myelodysplastic syndrome after treatment for acute promyelocytic leukemia.
    Pawarode A; Finlay E; Sait SN; Barcos M; Baer MR
    Cancer Genet Cytogenet; 2006 Jun; 167(2):155-60. PubMed ID: 16737916
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Therapy-related myelodysplastic syndrome or acute myelogenous leukemia in patients with acute promyelocytic leukemia (APL).
    Garcia-Manero G; Kantarjian HM; Kornblau S; Estey E
    Leukemia; 2002 Sep; 16(9):1888. PubMed ID: 12200720
    [No Abstract]   [Full Text] [Related]  

  • 15. Two independent clones in myelodysplastic syndrome following treatment of acute myeloid leukemia.
    Masuya M; Katayama N; Inagaki K; Miwa H; Hoshino N; Miyashita H; Suzuki H; Araki H; Mitani H; Nishii K; Kageyama S; Minami N; Shiku H
    Int J Hematol; 2002 Feb; 75(2):182-6. PubMed ID: 11939266
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Translocation (2;11)(q37;q23) in therapy-related myelodysplastic syndrome after treatment for acute promyelocytic leukemia.
    Snijder S; Mellink CH; van der Lelie H
    Cancer Genet Cytogenet; 2008 Jan; 180(2):149-52. PubMed ID: 18206542
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Therapy-related myelodysplastic syndrome/acute myeloid leukemia with del(7)(q22) in a patient with de novo AML.
    Kim YG; Cho SY; Park TS; Oh SH; Yoon HJ
    Ann Clin Lab Sci; 2011; 41(1):79-83. PubMed ID: 21325260
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Acute promyelocytic leukemia relapsing as secondary acute myelogenous leukemia with translocation t(3;21)(q26;q22) and RUNX1-MDS1-EVI1 fusion transcript.
    Park TS; Choi JR; Yoon SH; Song J; Kim J; Kim SJ; Kwon O; Min YH
    Cancer Genet Cytogenet; 2008 Dec; 187(2):61-73. PubMed ID: 19027486
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Myeloid neoplasms secondary to plasma cell myeloma: an intrinsic predisposition or therapy-related phenomenon? A clinicopathologic study of 41 cases and correlation of cytogenetic features with treatment regimens.
    Reddi DM; Lu CM; Fedoriw G; Liu YC; Wang FF; Ely S; Boswell EL; Louissaint A; Arcasoy MO; Goodman BK; Wang E
    Am J Clin Pathol; 2012 Dec; 138(6):855-66. PubMed ID: 23161720
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Secondary myelodysplastic syndrome after treatment for promyelocytic leukemia: clinical and genetic features of two cases.
    Panizo C; Patiño A; Lecumberri R; Calasanz MJ; Odero MD; Bendandi M; Rocha E
    Cancer Genet Cytogenet; 2003 Jun; 143(2):178-81. PubMed ID: 12781455
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.